Dolby Laboratories (NYSE:DLB) Posts Quarterly Earnings Results, Beats Estimates By $0.02 EPS

Dolby Laboratories (NYSE:DLB) issued its earnings results on Thursday. The electronics maker reported $0.69 earnings per share for the quarter, topping analysts’ consensus estimates of $0.67 by $0.02, FiscalAI reports. The business had revenue of $305.00 million for the quarter, compared to the consensus estimate of $311.96 million. Dolby Laboratories had a net margin of 17.85% and a return on equity of 11.47%. The firm’s revenue for the quarter was down 3.3% on a year-over-year basis. During the same period in the previous year, the company earned $0.78 earnings per share. Dolby Laboratories updated its FY 2026 guidance to 4.250-4.400 EPS and its Q4 2026 guidance to 1.130-1.280 EPS.

Here are the key takeaways from Dolby Laboratories’ conference call:

• Q4 revenue is expected to grow 23% year over year at the midpoint, reaching $362 million–$392 million, driven by a large Meta video-distribution deal, increased Dolby Atmos adoption in autos, wearables, and favorable minimum-volume-commitment timing.
• Dolby’s Video Distribution Program gained major licensees Meta and Alibaba, bringing the pool to 45 licensors and strengthening management’s confidence in reaching its goal of generating 10% of revenue from content partners by fiscal 2028.
• Automotive adoption continues to expand, with more than 40 OEM agreements and new launches from Volkswagen, Buick, and Google’s Android Auto partners; management said auto is Dolby’s fastest-growing end market and may be reported separately once it reaches 10% of licensing revenue.
• Fiscal 2026 revenue guidance was narrowed to $1.41 billion–$1.44 billion, while non-GAAP EPS is expected at $4.25–$4.40; the company is targeting approximately 100 basis points of operating-margin improvement and authorized an additional $350 million for share repurchases.
• Management is monitoring elevated memory costs, which could pressure mobile and PC unit shipments and product launches, although the company expects growth in video distribution, automotive, and wearables to offset part of the impact.

Dolby Laboratories Price Performance

DLB traded up $6.12 during trading on Friday, hitting $57.90. The stock had a trading volume of 581,372 shares, compared to its average volume of 811,383. The company has a 50 day moving average price of $52.21 and a 200-day moving average price of $58.58. Dolby Laboratories has a one year low of $48.26 and a one year high of $75.80. The firm has a market cap of $5.48 billion, a price-to-earnings ratio of 22.87 and a beta of 0.81.

Dolby Laboratories Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Wednesday, August 19th. Investors of record on Tuesday, August 11th will be issued a dividend of $0.36 per share. This represents a $1.44 annualized dividend and a yield of 2.5%. The ex-dividend date of this dividend is Tuesday, August 11th. Dolby Laboratories’s dividend payout ratio (DPR) is presently 56.92%.

Dolby Laboratories announced that its board has initiated a stock buyback plan on Thursday, July 30th that permits the company to repurchase $350.00 million in shares. This repurchase authorization permits the electronics maker to purchase up to 7% of its stock through open market purchases. Stock repurchase plans are often a sign that the company’s board of directors believes its stock is undervalued.

Analyst Ratings Changes

A number of equities research analysts have recently issued reports on DLB shares. Rosenblatt Securities reaffirmed a “buy” rating and issued a $85.00 target price on shares of Dolby Laboratories in a report on Friday. Wall Street Zen raised Dolby Laboratories from a “hold” rating to a “buy” rating in a research report on Saturday, May 30th. Barrington Research restated an “outperform” rating and issued a $90.00 price objective on shares of Dolby Laboratories in a research note on Monday, June 15th. Finally, Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Dolby Laboratories in a research report on Wednesday, June 24th. Three analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $90.75.

Insider Transactions at Dolby Laboratories

In other news, SVP John D. Couling sold 7,667 shares of Dolby Laboratories stock in a transaction on Wednesday, July 1st. The stock was sold at an average price of $53.20, for a total transaction of $407,884.40. Following the completion of the sale, the senior vice president owned 118,727 shares of the company’s stock, valued at approximately $6,316,276.40. This trade represents a 6.07% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CFO Robert J. Park sold 4,895 shares of the business’s stock in a transaction dated Tuesday, May 12th. The shares were sold at an average price of $56.68, for a total transaction of $277,448.60. Following the completion of the sale, the chief financial officer directly owned 81,490 shares of the company’s stock, valued at approximately $4,618,853.20. The trade was a 5.67% decrease in their position. The SEC filing for this sale provides additional information. Insiders have sold 47,458 shares of company stock worth $2,639,537 over the last quarter. 37.93% of the stock is currently owned by corporate insiders.

Institutional Trading of Dolby Laboratories

A number of institutional investors have recently bought and sold shares of the business. EntryPoint Capital LLC boosted its stake in shares of Dolby Laboratories by 56.5% in the fourth quarter. EntryPoint Capital LLC now owns 6,518 shares of the electronics maker’s stock valued at $419,000 after buying an additional 2,352 shares during the period. Bank of Nova Scotia increased its stake in Dolby Laboratories by 9.6% during the 4th quarter. Bank of Nova Scotia now owns 6,055 shares of the electronics maker’s stock worth $389,000 after acquiring an additional 528 shares during the period. Federation des caisses Desjardins du Quebec increased its stake in Dolby Laboratories by 18.2% during the 4th quarter. Federation des caisses Desjardins du Quebec now owns 4,839 shares of the electronics maker’s stock worth $311,000 after acquiring an additional 744 shares during the period. Abel Hall LLC acquired a new position in Dolby Laboratories in the 4th quarter valued at $309,000. Finally, Boothbay Fund Management LLC raised its holdings in Dolby Laboratories by 4.1% in the 2nd quarter. Boothbay Fund Management LLC now owns 4,020 shares of the electronics maker’s stock valued at $299,000 after acquiring an additional 157 shares in the last quarter. Institutional investors own 58.56% of the company’s stock.

Dolby Laboratories News Summary

Here are the key news stories impacting Dolby Laboratories this week:

• Positive Sentiment: Adjusted earnings beat estimates: Dolby reported fiscal Q3 adjusted EPS of $0.69, above the $0.67 consensus estimate, helped by lower operating expenses. Dolby’s Q3 Earnings Beat Estimates on Lower Operating Expenses
• Positive Sentiment: Upbeat fourth-quarter outlook: Dolby forecast fiscal Q4 revenue of $362 million to $392 million, above the $351.1 million analyst estimate. Q4 EPS guidance of $1.13 to $1.28 also brackets the $1.16 consensus, while full-year EPS guidance of $4.25 to $4.40 exceeds the $4.10 estimate. Management cited momentum in video licensing, automotive applications, and new device categories.
• Positive Sentiment: $350 million buyback authorized: The repurchase plan allows Dolby to buy back up to 7% of its outstanding shares. The authorization may support earnings per share and signals that management believes the stock is undervalued. Dolby Laboratories share repurchase report
• Positive Sentiment: Analyst support continued: Rosenblatt Securities reaffirmed its “buy” rating and $85 price target, implying substantial upside from recent trading levels. Benzinga analyst rating report
• Neutral Sentiment: Dividend maintained: Dolby declared a quarterly dividend of $0.36 per share, payable August 19 to shareholders of record August 11. The dividend provides ongoing shareholder returns but is unlikely to be the primary catalyst.
• Negative Sentiment: Revenue and reported profitability declined: Q3 revenue fell 3.3% year over year to $305 million, missing estimates near $312 million. Reported EPS declined from $0.78 to $0.30, while operating profit and net income also fell, highlighting weaker current-quarter business trends.
• Negative Sentiment: Insider selling is a cautionary signal: Disclosed activity showed multiple insiders selling shares over the past six months with no reported insider purchases. This does not necessarily indicate deteriorating fundamentals, but may temper investor enthusiasm.

About Dolby Laboratories

Dolby Laboratories, Inc is a global leader in audio and imaging technologies, specializing in the development, licensing and deployment of solutions that enhance entertainment and communications experiences. The company’s core business revolves around creating advanced audio codecs, noise reduction systems and spatial sound technologies for a wide range of applications, including cinema, broadcast, gaming, streaming and personal devices. Dolby’s licensing model enables consumer electronics manufacturers, content creators and service providers to integrate its technologies into products such as televisions, smartphones, home theater systems and set-top boxes.

Among its flagship innovations are Dolby Atmos, an immersive audio format that delivers three-dimensional soundscapes for theaters and home systems; Dolby Digital and Dolby Digital Plus, widely adopted audio compression formats for broadcast and streaming; and Dolby Vision, a high-dynamic-range imaging technology that expands color, contrast and brightness in displays.